At Stark Pharma, we provide comprehensive Quality Assurance (QA) and Software Testing services designed for pharmaceutical, medical device, and healthcare technology applications. Our validation-driven approach ensures that your software performs consistently, meets regulatory expectations, and supports audit readiness—whether it's a clinical application, SaMD, or enterprise software platform.
We perform end-to-end functional testing to validate that every feature behaves as expected. Our regression testing services ensure system stability after each update or release, with reusable test cases for future cycles.
We develop and maintain automated test scripts using Selenium, Cypress, TestComplete, and Appium to reduce manual efforts and accelerate release cycles—especially effective for high-volume or complex applications.
Our QA teams validate application performance under varying loads and conduct stress testing to identify bottlenecks. We also test for vulnerabilities and implement security testing protocols to protect sensitive healthcare data.
We specialize in testing software in compliance with GAMP 5, 21 CFR Part 11, EU Annex 11, HIPAA, and ISO 13485. We generate complete validation documentation including IQ/OQ/PQ, traceability matrices, test scripts, and summary reports.
We ensure optimal performance across devices, browsers, and operating systems—critical for patient-facing apps, clinician portals, and global regulatory tools.
We support User Acceptance Testing (UAT) processes, triage defects, and work closely with development teams to ensure quick resolution and accurate revalidation.
We bring life sciences domain knowledge, regulatory understanding, and hands-on CSV expertise to every QA engagement—ensuring your system is inspection-ready.
Our QA strategy blends manual rigor with intelligent automation to enhance coverage, accuracy, and efficiency without sacrificing traceability.
From requirements analysis to release sign-off, we embed quality throughout the software development lifecycle—minimizing risks and defects in production.